Flow is Life

Learn More

The Future in Treating

Distal Vessel Occlusions

Pulse NanoMED:
A Next Generation Interventional Device

A first of its kind nano-scale medical device designed to extend beyond the reach of wires and catheters.

The Pulse NanoMED™ System is a nanoscale interventional tool to help diagnose and treat complex vascular occlusions unreachable with existing treatments. Under the influence of an external rotating magnet, the iron-oxide nanoparticles can reach and disrupt distal vessel occlusions.

Acute Ischemic Stroke
(AIS)

Stroke occurs when there is a halt in blood flow to the brain.  In the majority of stroke cases, an artery becomes obstructed by a blood clot. The blood clot must be cleared to restore flow and allow for brain tissue to remain viable.

The goal of every interventionalist is to restore blood flow and achieve Total Tissue Reperfusion (TTR).

Current Stroke treatments involve extracting the blood clot with catheter-based systems and/or via the administration of a clot-busting drug that “melts” the clot over time.  As a blood vessel becomes obstructed, it presents a challenge for the flow of blood to reach the clot and by nature, that of the clot-busting drug to reach the clot as well. If the clot-busting drug cannot reach the clot, it cannot perform its intended job.

In stroke, the Pulse NanoMED™ system assists in the delivery of life-saving therapeutics, in the pursuit of TTR and the restoration of life-saving blood flow.

ST Elevated Myocardial Infarction (STEMI)

ST-Elevation Myocardial Infarction (STEMI) is a severe type of heart attack caused by a complete blockage of a coronary artery, resulting in a significant reduction or cessation of blood flow to a region of the heart muscle. This blockage typically occurs due to the formation of a blood clot, leading to ischemia and potential damage to the heart tissue. Prompt and effective restoration of blood flow is crucial to minimize myocardial damage and improve patient outcomes. Current standard treatments for STEMI involve mechanical interventions such as percutaneous coronary intervention (PCI) or thrombolytic therapy to restore blood flow in the affected coronary artery.

The Pulse NanoMED™ system is designed to address distal vascular occlusions and the "no reflow" phenomenon encountered in STEMI. Under the influence of a magnet, the iron-oxide nanoparticles can disrupt clots and restore blood flow to improve the outcomes for STEMI patients and reduce the risk of complications.

Peripheral Arterial Disease
(PAD)

PAD is a common circulatory problem in which narrowed arteries reduce the flow of blood to limbs.  When PAD progresses, it can lead to significant pain, wounds, amputation, infection and death. The more advanced form of PAD is Critical Limb Threatening Ischemia (CLTI).

The goal of every interventionalist, in the treatment of CLTI is to restore blood flow and achieve Total Tissue Reperfusion (TTR).  When corrected, limbs can be salvaged and lives can be saved.  Current devices designed to treat CLTI (angioplasty balloons, stents, atherectomy systems, etc), are effective but limited in their capacity to navigate and treat important, smaller, more tortuous and distal arteries.

In CLTI, the Pulse NanoMED™ system addresses tougher to reach areas in the pursuit of TTR and the restoration of life-saving blood flow.

Disruptive

Extends beyond the reach of wires and catheters to treat vascular occlusions

Life-Saving

A first of its kind technology to achieve better, more comprehensive reperfusion

More Comprehensive

Optimizing reperfusion head to toe for vascular occlusions

Better Health Economics

Better outcomes and getting patients out of hospitals faster equals better economics in treating vascular occlusions

Our Team

What Physicians Say

“The potential of MED in helping physicians to have further reach, to identify areas of flow hidden by traditional means and to translate in, around and through vascular occlusions could be transformative.”

Craig Walker, MD

Partner with Us

Experienced Team

Patented Platform

NIH Awards

News

Pulse Therapeutics Supports Stroke Awareness Month in May

Stroke is Preventable in 80% of Cases Recognizing Warning Signs, By Adopting Healthy Lifestyle The devastating impact of stroke, the nation’s fourth deadliest disease, is undeniable. Stroke impacts 795,000 people each year, according to the American Heart Association/American Stroke Association (AHA/ASA).…

Read More

Pulse Therapeutics’ MED System Featured by Horizon Scanning Research & Intelligence Centre

Pulse Therapeutics Featured in Med Device Online

Pulse CEO Featured in St. Louis Business Journal

Read News

Are you ready to 
Make a Difference?

Get in Touch